Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Stoke Therapeutics (STOK) Receivables - Net (2024 - 2025)

Stoke Therapeutics (STOK) has 2 years of Receivables - Net data on record, last reported at $9.2 million in Q3 2025.

  • For Q3 2025, Receivables - Net changed N/A year-over-year to $9.2 million; the TTM value through Sep 2025 reached $9.2 million, changed N/A, while the annual FY2024 figure was $1.7 million, N/A changed from the prior year.
  • Receivables - Net reached $9.2 million in Q3 2025 per STOK's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $9.2 million in Q3 2025 and bottomed at $1.7 million in Q4 2024.